Cargando…

White matter alterations in antipsychotic- and mood stabilizer-naïve individuals with bipolar II/NOS disorder()

Structural magnetic resonance imaging (MRI) studies using voxel-based morphometry (VBM) and tract-based spatial statistics (TBSS) have been inconsistent in demonstrating impairments in gray matter (GM) and white matter (WM) structures in bipolar disorder (BD). This may be a consequence of significan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yip, Sarah W., Chandler, Rebecca A., Rogers, Robert D., Mackay, Clare E., Goodwin, Guy M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3814955/ https://www.ncbi.nlm.nih.gov/pubmed/24273712 http://dx.doi.org/10.1016/j.nicl.2013.08.005

Ejemplares similares

Borderline Personality Disorder: Bipolarity, Mood Stabilizers and Atypical Antipsychotics in Treatment
por: Belli, Hasan, et al.
Publicado: (2012)

Antipsychotics and mood stabilizers on risk for hepatic failure in people with schizophrenia and bipolar disorder
por: Tascón Guerra, M.F., et al.
Publicado: (2022)

Regularity of self-reported daily dosage of mood stabilizers and antipsychotics in patients with bipolar disorder
por: Pilhatsch, Maximilian, et al.
Publicado: (2018)

Mood stability versus mood instability in bipolar disorder: A possible role for emotional mental imagery
por: Holmes, Emily A., et al.
Publicado: (2011)

Mood dynamics in bipolar disorder
por: Moore, Paul J, et al.
Publicado: (2014)

Nonlinear time-series approaches in characterizing mood stability and mood instability in bipolar disorder
por: Bonsall, M. B., et al.
Publicado: (2012)

White matter integrity in young medication-naïve bipolar II depressed adults
por: Mak, Arthur Dun Ping, et al.
Publicado: (2021)

Impaired interactions among white‐matter functional networks in antipsychotic‐naive first‐episode schizophrenia
por: Fan, Yun‐Shuang, et al.
Publicado: (2019)

Pharmacogenomics of Mood Stabilizers in the Treatment of Bipolar Disorder
por: Squassina, Alessio, et al.
Publicado: (2010)

Therapeutic monitoring of mood stabilizers in bipolar disorder
por: Falfel, D., et al.
Publicado: (2021)

Mood stabilizers and/or antipsychotics for bipolar disorder in the maintenance phase: a systematic review and network meta-analysis of randomized controlled trials
por: Kishi, Taro, et al.
Publicado: (2020)

Mood Stabilisers, but for Lithium, are not stabilizing Moods! Bipolar Disorders: Clinical conundrums 2
por: Reddy, M. S., et al.
Publicado: (2017)

Alterations in white matter network dynamics in patients with schizophrenia and bipolar disorder
por: Wang, Bin, et al.
Publicado: (2022)

Association between gray/white matter contrast and white matter microstructural alterations in medication-naïve obsessive–compulsive disorder
por: Niu, Qihui, et al.
Publicado: (2022)

White Matter Integrity, Duration of Untreated Psychosis, and Antipsychotic Treatment Response in Medication-Naïve First Episode Psychosis Patients
por: Kraguljac, Nina Vanessa, et al.
Publicado: (2020)

Management of bipolar depression with lamotrigine: an antiepileptic mood stabilizer
por: Prabhavalkar, Kedar S., et al.
Publicado: (2015)

Trajectories of adherence to mood stabilizers in patients with bipolar disorder
por: Bauer, M., et al.
Publicado: (2019)

RNA Biomarkers in Bipolar Disorder and Response to Mood Stabilizers
por: Pisanu, Claudia, et al.
Publicado: (2023)

Effectiveness of mood stabilizers in prophylactic treatment of bipolar disorder
por: Khattech, D., et al.
Publicado: (2023)

The common bipolar phenotype in young people
por: Rock, Philippa L, et al.
Publicado: (2013)

Profiling the Skeletal Muscle Proteome in Patients on Atypical Antipsychotics and Mood Stabilizers
por: Burghardt, Kyle J., et al.
Publicado: (2022)

Altered Neuronal Markers Following Treatment with Mood Stabilizer and Antipsychotic Drugs Indicate an Increased Likelihood of Neurotransmitter Release
por: Scarr, Elizabeth, et al.
Publicado: (2012)

White matter alterations in drug-naïve children with Tourette syndrome and obsessive-compulsive disorder
por: Bharti, Komal, et al.
Publicado: (2022)

Stabilization Beyond Mood: Stabilizing Patients With Bipolar Disorder in the Various Phases of Life
por: Simonetti, Alessio, et al.
Publicado: (2020)

Grey matter connectome abnormalities and age-related effects in antipsychotic-naive schizophrenia
por: Yang, Beisheng, et al.
Publicado: (2021)

T154. WHITE MATTER INTEGRITY, DURATION OF UNTREATED PSYCHOSIS, AND ANTIPSYCHOTIC TREATMENT RESPONSE IN MEDICATION-NAïVE FIRST EPISODE PSYCHOSIS PATIENTS
por: Kraguljac, Nina, et al.
Publicado: (2020)

Alterations of Intrinsic Connectivity Networks in Antipsychotic-Naïve First-Episode Schizophrenia
por: Anhøj, Simon, et al.
Publicado: (2018)

Meta-analysis of regional white matter volume in bipolar disorder with replication in an independent sample using coordinates, T-maps, and individual MRI data
por: Pezzoli, Stefania, et al.
Publicado: (2018)

Age-Related Alterations of White Matter Integrity in Adolescents and Young Adults With Bipolar Disorder
por: Ren, Sihua, et al.
Publicado: (2020)

White matter pathology – an endophenotype for bipolar disorder?
por: Borgwardt, Stefan, et al.
Publicado: (2012)

White Matter Tract Alterations in Drug-Naïve Parkinson’s Disease Patients With Impulse Control Disorders
por: Mojtahed Zadeh, Mahtab, et al.
Publicado: (2018)

White Matter Tract Alterations in Drug-Naïve Parkinson's Disease Patients With Excessive Daytime Sleepiness
por: Ashraf-Ganjouei, Amir, et al.
Publicado: (2019)

Application of Antipsychotic Drugs in Mood Disorders
por: Rybakowski, Janusz K.
Publicado: (2023)

Comparison of White Matter Structure of Drug-Naïve Patients With Bipolar Disorder and Major Depressive Disorder Using Diffusion Tensor Tractography
por: Koreki, Akihiro, et al.
Publicado: (2022)

Mental imagery in bipolar affective disorder versus unipolar depression: Investigating cognitions at times of ‘positive’ mood
por: Ivins, Annabel, et al.
Publicado: (2014)

General pharmacokinetic/pharmacodynamic concepts of mood stabilizers in the treatment of bipolar disorder
por: Ware, Kenric, et al.
Publicado: (2016)

Aripiprazole Augmentation to Mood Stabilizers for Obsessive-Compulsive Symptoms in Bipolar Disorder
por: Di Salvo, Gabriele, et al.
Publicado: (2020)

Hamlet’s augury: how to manage discontinuation of mood stabilizers in bipolar disorder
por: Qureshi, Mutahira M., et al.
Publicado: (2021)

Neuromolecular Etiology of Bipolar Disorder: Possible Therapeutic Targets of Mood Stabilizers
por: Lee, Jung Goo, et al.
Publicado: (2022)

Childhood maltreatment and clinical response to mood stabilizers in patients with bipolar disorder
por: Attianese, N., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mps427grd7muthi5f369vqmqlf